ASX ANNOUNCEMENT 5 August 2026 1 Results of Extraordinary General Meeting In accordance with Listing Rule 3.13.2 and section 251AA(1) of the Corporations Act 2001 (Cth), please find attached the results of the resolutions put to shareholders today at the 2026 Extraordinary...
Results of Meeting
Filed with ASX · · 3 pages · English
Release
Bio-Gene Technology Ltd. on 6ix
Earlier from Bio-Gene Technology
- Quarterly Activities/Appendix 4C Cash Flow Report
- Results of Placement
- Sumitomo & Nakashima to launch Qcide products in Japan
- Regulatory Development of Flavocide
- Appendix 4D and Half-Year Accounts 31 December 2025
Later from Bio-Gene Technology
- Application for quotation of securities - BGT
- Placement Completed and Cleansing Notice
- Change of Director's Interest Notice x 4
- Notification regarding unquoted securities - BGT
- Change in substantial holding
Follow Bio-Gene Technology into a list and get an email when it puts out news.
Follow Bio-Gene Technology